4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008711
Director sold 19,289 shares at an average $8.49 ($163,673)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD Director | 2025-03-18 | Sale | −10,382 | $8.67 | $90,012 | 148,253 | D |
| Kaye Edward M. MD Director | 2025-03-19 | Sale | −8,907 | $8.27 | $73,661 | 139,346 | D |
| Derivatives | |||||||
| Kaye Edward M. MD Director | 2025-03-20 | Grant or award · Employee Stock Option (Right to Buy) | +216,000 | 216,000 | D | ||
| Kaye Edward M. MD Director | 2025-03-20 | Grant or award · Restricted Stock Units | +144,000 | 144,000 | D | ||
| Open-market sales · 19,289 sh · avg $8.49 · $163,673 | |||||||
Loading xslF345X05/form4-03202025_100313.xml…